[Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?]. / Terapêutica trombolítica no enfarte agudo do miocárdio--estará a ser utilizada em pleno?

OBJECTIVE: To evaluate the experience with thrombolytic therapy (TT) in the treatment of patients with the discharge diagnosis of acute myocardial infarction (AMI). DESIGN: Retrospective analysis of the clinical records of patients with the discharge diagnosis of AMI, between May 1988 and December 1995. SETTING: Intensive Cardiac Care Unit (UCIM-Medicina IV) of Santa Maria University Hospital, Lisbon, Portugal. PATIENTS: 1319 patients, 958 men (73%) and 361 women, mean age 64 +/- 12 years. MAIN RESULTS: Thrombolytic therapy was administered in 391 patients (30%). Female patients received less thrombolytic therapy compared with male (17% vs. 34%; p < 0.001). Anterior wall infarction was more frequent (38%). Patients in Killip class I-II (77%) received more thrombolytic therapy than class III-IV (33% vs. 17%). The utilization rate of thrombolytic therapy increased from 25% in 1988 to 34% in 1995. Two major categories of patients were not treated with thrombolysis: 1) patients presented more than 12 hours after pain onset (38%); 2) patients without ST segment elevation or LBBB on the ECG presented (37%). Overall hospital mortality was 15.6%. The mortality in patients receiving thrombolytic therapy was significantly lower than in those excluded (9.4% vs. 18.2%; p < 0.001). CONCLUSION: Only 30% of patients with AMI receive TT. Of those excluded from this important therapeutic intervention, 75% had no ECG criteria or were outside the standard therapeutic "window". This significant group of patients need new diagnostic and intervention strategies.

[Thrombolysis in acute myocardial infarct. Experience at Santa Maria's Hospital]. / Trombólise no enfarte agudo do miocárdio Experiência no Hospital de Santa Maria.

OBJECTIVES: To evaluate the experience with i.v. streptokinase (SK) in the treatment of acute myocardial infarction (AMI) in two cardiac care units. Conception: Retrospective analysis of patients (pts) admitted either to UCIM or UTIC-AC with the diagnosis of AMI receiving SK. PATIENTS: 77 pts were treated, although one of them was later proved to be a false positive diagnosis of AMI. Of the other 76, there were 63 men and 13 women with age 55 +/- 12 (mean age +/- SD) years (limits of 20 and 82 years). AMIs were anterior in 42% of the pts, inferior in 51%, anterior and inferior in 4% and non Q wave in 1%; Killip classes (cl) were: cl I in 64%, cl II in 26%, cl III in 5% an cl IV in 5%. The time interval from the beginning of acute symptoms to the arrival at the hospital was 2.8 +/- 1.2 hours (1 to 15) and from that moment to administration of SK was 1.6 +/- 1.4 h. The whole interval to the administration of SK was 4.4 +/- 2.5 h. RESULTS: The 3 criteria of reperfusion (pain relief, ST changes resolution and less than 18 h maximum CK rise) were present in 36% of the pts, 2 of the criteria in 21%, and 41% of the pts had only one or no criteria. The time interval to the administration of SK in these 3 groups was 3.3 +/- 1.3 h, 4.8 +/- 3.1 h and 5.0 +/- 2.5 h respectively. Non fatal complications occurred in 16% of the pts (major bleeding in 2.6%, minor bleeding in 99% and minor anafilaxy in 4%. Mortality was 11.8% (9 pts). Two thirds of the deaths were due to cardiac rupture. In hospital residual ischemia was present in 9% (7 pts). CONCLUSION: Treatment of AMI with i.v. SK proved to be a safe and easy to apply therapeutic option, carrying a low morbidity and mortality, lower than that normally observed in our hospital with the conventional approach of AMI before the era of thrombolysis.

Acute limb ischemia as manifestation of a pheochromocytoma.

A case is described of a woman admitted to the emergency room with myocardial infarction and acute leg ischemia and suspected thromboembolism. Surgical exploration of the common femoral artery and its branches was performed. The surgical outcome and the subsequent clinical course suggested the diagnosis of pheochromocytoma which was supported by isotopic red-cell labelling study and catecholamine measurement. The very high values of catecholamine production explained the marked and persistent arterial vasospasm which led to marked and irreversible ischemia.